No Gain From P-Selectin-Blocking Agent in Hospitalized COVID at AshTip Solution.

AshTip NewsLetter |Crizanlizumab does not affect mortality or the number of days free of respiratory or cardiovascular (CV) organ-support measures in hospitalized patients with COVID-19.

Medscape

No Gain From P-Selectin-Blocking Agent in Hospitalized COVID

No Gain From P-Selectin-Blocking Agent in Hospitalized COVID

Crizanlizumab does not affect mortality or the number of days free of respiratory or cardiovascular (CV) organ-support measures in hospitalized patients with COVID-19.